[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # $mnpr Monopar Therapeutics (MNPR) sees a significant surge in social engagements, up XXXXX% week-over-week, driven by positive sentiment around stock performance and drug development. Analysts are issuing outperform ratings with price targets as high as $XXX. ### About $mnpr Monopar Therapeutics (MNPR) is a biotechnology company focused on developing treatments for rare diseases. ### Insights - $mnpr engagements is up XXXXX% from the previous week. ### Engagements: XXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$mnpr/time-series/interactions.tsv) Current Value: XXX Daily Average: XXXXX X Week: XXXXX +26% X Month: XXXXXX -XX% X Months: XXXXXXX +23% X Year: XXXXXXXXX -XX% 1-Year High: XXXXXXX on 2025-10-20 1-Year Low: XX on 2025-06-15 Engagements by network (24h): X: XXX ### Mentions: XX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$mnpr/time-series/posts_active.tsv) Current Value: XX Daily Average: XX X Week: XX -XX% X Month: XXX -XX% X Months: XXXXX +487% X Year: XXXXX +232% 1-Year High: XXX on 2025-08-27 1-Year Low: X on 2025-12-07 Mentions by network (24h): X: XX ### Creators: X (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$mnpr/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $mnpr in the last XX hours which is down XX% from X in the previous XX hours Daily Average: XX X Week: XX -XX% X Month: XX -XX% X Months: XXXXX +1,464% X Year: XXXXX +551% 1-Year High: XXX on 2025-08-27 1-Year Low: X on 2025-12-07 The most influential creators that mention $mnpr in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@kjerath](/creator/twitter/kjerath) | X | XXX | X | XX | | [@notreload_ai](/creator/twitter/notreload_ai) | X | XXXXX | X | X | [View More](/list/creators/$mnpr/100) ### Sentiment: XXX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$mnpr/time-series/sentiment.tsv) Current Value: XXX% Daily Average: XX% X Week: XXX% no change X Month: XXX% no change X Months: XXX% +50% X Year: XXX% no change 1-Year High: XXX% on 2025-01-22 1-Year Low: XX% on 2025-07-25 Most Supportive Themes: - Stock Performance and Investment Potential: (40%) Posts highlight Monopar Therapeutics (MNPR) as a top performer and a potential investment, citing significant percentage gains and analyst target raises. - Biotech Drug Development and Approvals: (30%) Discussions focus on Monopar's drug development, particularly for Wilson disease, and the potential for FDA approval, indicating significant progress and future prospects. - Market Trends and Mentions in Hype Cycles: (20%) MNPR is frequently mentioned alongside other trending stocks during periods of high social media hype, suggesting its inclusion in broader market discussions and speculative interest. Most Critical Themes: - Past Development Setbacks and Acquisition: (10%) While positive, some posts allude to the drug's history, including AstraZeneca's termination of development due to an 'inadvertent error,' which Monopar later acquired and corrected. ### Top $mnpr Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$SUGP hype is insane like the prime days of SMX $HKD $TOP $GME $DJT $PHUN $HOLO $MLGO $FFAI $AMC $NEGG $CVNA $MNPR $NUKK" [X Link](https://x.com/Jokerparabol/status/1998527543180484784) [@Jokerparabol](/creator/x/Jokerparabol) 2025-12-09T22:57Z 6610 followers, XXX engagements "$MNPR $NVDA $MLGO To Analyst price target for next week-" [X Link](https://x.com/Chat3Free/status/1998392787520368867) [@Chat3Free](/creator/x/Chat3Free) 2025-12-09T14:02Z XXX followers, XX engagements "$ONDS š„Major Money Deals Incomingš„ $FCX $FDS $FE $FFIV $FICO $FIS $FISV $FITB $FOX $FOXA $FRT $FSLR $FTNT $FTV $GDDY $GEHC $GEN $GILD $GIS $MAJI $MEDCL $MGOL $MGX $GLW $GM $GNRC $GOOG $GPC $GPN $GRMN $GS $GWW $HAL $HAS $HBAN $HCA $MNPR $MODG $MSO $NOW" [X Link](https://x.com/Newbie_AAA/status/1998113474870997300) [@Newbie_AAA](/creator/x/Newbie_AAA) 2025-12-08T19:32Z XX followers, XXX engagements "for data since NXP-800 failed because if NXP-900 works it doesn't matter if they buy at $X or $XX or $XX - it's still a home run. But at $X the potential for $NVCT is similar to $AXSM and $MNPR in terms of returns. Now management must deliver" [X Link](https://x.com/kjerath/status/1996217652214202535) [@kjerath](/creator/x/kjerath) 2025-12-03T13:59Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Monopar Therapeutics (MNPR) sees a significant surge in social engagements, up XXXXX% week-over-week, driven by positive sentiment around stock performance and drug development. Analysts are issuing outperform ratings with price targets as high as $XXX.
Monopar Therapeutics (MNPR) is a biotechnology company focused on developing treatments for rare diseases.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +26%
X Month: XXXXXX -XX%
X Months: XXXXXXX +23%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-10-20
1-Year Low: XX on 2025-06-15
Engagements by network (24h): X: XXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +487%
X Year: XXXXX +232%
1-Year High: XXX on 2025-08-27
1-Year Low: X on 2025-12-07
Mentions by network (24h): X: XX
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $mnpr in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XX -XX%
X Months: XXXXX +1,464%
X Year: XXXXX +551%
1-Year High: XXX on 2025-08-27
1-Year Low: X on 2025-12-07
The most influential creators that mention $mnpr in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @kjerath | X | XXX | X | XX |
| @notreload_ai | X | XXXXX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% +50%
X Year: XXX% no change
1-Year High: XXX% on 2025-01-22
1-Year Low: XX% on 2025-07-25
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SUGP hype is insane like the prime days of SMX $HKD $TOP $GME $DJT $PHUN $HOLO $MLGO $FFAI $AMC $NEGG $CVNA $MNPR $NUKK"
X Link @Jokerparabol 2025-12-09T22:57Z 6610 followers, XXX engagements
"$MNPR $NVDA $MLGO To Analyst price target for next week-"
X Link @Chat3Free 2025-12-09T14:02Z XXX followers, XX engagements
"$ONDS š„Major Money Deals Incomingš„ $FCX $FDS $FE $FFIV $FICO $FIS $FISV $FITB $FOX $FOXA $FRT $FSLR $FTNT $FTV $GDDY $GEHC $GEN $GILD $GIS $MAJI $MEDCL $MGOL $MGX $GLW $GM $GNRC $GOOG $GPC $GPN $GRMN $GS $GWW $HAL $HAS $HBAN $HCA $MNPR $MODG $MSO $NOW"
X Link @Newbie_AAA 2025-12-08T19:32Z XX followers, XXX engagements
"for data since NXP-800 failed because if NXP-900 works it doesn't matter if they buy at $X or $XX or $XX - it's still a home run. But at $X the potential for $NVCT is similar to $AXSM and $MNPR in terms of returns. Now management must deliver"
X Link @kjerath 2025-12-03T13:59Z XXX followers, XXX engagements
/topic/$mnpr